The Federal Register

Agency Information Collection Activities: Proposed Collection; Comments Requested

Thu, Nov 20 2008 11:00:00 GMT

The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register at 73 FR 53278 on September 15, 2008, allowing for a 60day comment period.

The purpose of this notice is to allow for an additional 30 days for public comment until December 22, 2008. This process is conducted in accordance with 5 CFR 1320.10.

Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer,

Agency Information Collection Activities: Proposed Collection; Comments Requested

Thu, Nov 20 2008 11:00:00 GMT

The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register at 73 FR 53279 on September 15, 2008, allowing for a 60 day comment period.

The purpose of this notice is to allow for an additional 30 days for public comment until December 22, 2008. This process is conducted in accordance with 5 CFR 1320.10.

Agency Information Collection Activities: Proposed Collection; Comments Requested

Thu, Nov 20 2008 11:00:00 GMT

The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register at 73 FR 53280 on September 15, 2008, allowing for a 60 day comment period.

The purpose of this notice is to allow for an additional 30 days for public comment until December 22, 2008. This process is conducted in accordance with 5 CFR 1320.10.

Exempt Chemical Mixtures Containing Gamma-Butyrolactone

Wed, Nov 12 2008 11:00:00 GMT

DEA is proposing that chemical mixtures that are 70 percent or less gammabutyrolactone (GBL), by weight or volume, be automatically exempt from regulatory controls under the Controlled Substances Act (CSA). DEA is seeking through this rulemaking to exempt only those chemical mixtures that do not represent a significant risk of diversion. If finalized as proposed, this regulation would result in GBL chemical mixtures, in concentrations greater than 70 percent, becoming subject to List I chemical regulatory requirements of the CSA, except if exempted through an existing categorical exemption. DEA is taking this action because there is a serious threat to the public safety associated with the ease by which GBL is chemically converted to the schedule I controlled substance gammahydroxybutyric acid (GHB).

DEA recognizes that concentration criteria alone cannot identify all mixtures that warrant exemption. As a result, 21 CFR 1310.13 provides for an application process by which manufacturers may o

Controlled Substances: Final Revised Aggregate Production Quotas for 2008

Wed, Nov 12 2008 11:00:00 GMT

This notice establishes final 2008 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA). The DEA has taken into consideration comments received in response to a notice of the proposed revised aggregate production quotas for 2008 published July 1, 2008 (73 FR 37496).

Controlled Substances: Proposed Aggregate Production Quotas for 2009

Fri, Nov 7 2008 11:00:00 GMT

This notice proposes initial year 2009 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA).

Drug Enforcement Administration

Fri, Nov 7 2008 11:00:00 GMT

Importer of Controlled Substances; Notice of Registration

By Notice dated July 29, 2008, and published in the Federal Register on August 6, 2008, (73 FR 45780), Wildlife Laboratories, 1401 Duff Drive, Suite 400, Fort Collins, Colorado 80524, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Etorphine Hydrochloride (9059), a basic class of controlled substance listed in schedule II.

The company plans to import the listed controlled substance for sale to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Wildlife Laboratories to import the basic class of controlled substance is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Wildlife Laboratories to ensure that the company's regist

Manufacturer of Controlled Substances; Notice of Application

Mon, Nov 3 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 15, 2008, Cedarburg Pharmaceuticals, Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Tetrahydrocannabinols (7370)............... I
Dihydromorphine (9145)..................... I
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Remifentanil (9739)........................ II
Sufentanil (9740).......................... II

Fentanyl (9801)............................ II

The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.

Any other such applicant, and a

Agency Information Collection Activities: Proposed Collection; Comments Requested

Thu, Oct 30 2008 11:00:00 GMT

The Department of Justice (DOJ), Drug Enforcement Administration (DEA) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register at 73 FR 50055 on August 25, 2008, allowing for a 60day comment period.

The purpose of this notice is to allow for an additional 30 days for public comment until December 1, 2008. This process is conducted in accordance with 5 CFR 1320.10.

Importer of Controlled Substances; Notice of Registration

Tue, Oct 28 2008 11:00:00 GMT

By Notice dated July 30, 2008 and published in the Federal Register on August 6, 2008 (73 FR 45781), Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Phenylacetone (8501), a basic class of controlled substance listed in schedule II.

The company plans to import the listed controlled substance to bulk manufacture amphetamine.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Boehringer Ingelheim Chemicals, Inc. to import the basic class of controlled substance is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Boehringer Ingelheim Chemicals, Inc. to ensure that the company's registration is consistent wit

Final Revised Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine

Mon, Oct 27 2008 11:00:00 GMT

This notice establishes the Final Revised 2008 Assessment of Annual Needs for certain List I chemicals in accordance with the Combat Methamphetamine Epidemic Act of 2005 (CMEA), enacted on March 9, 2006.

Importer of Controlled Substances; Notice of Application

Fri, Oct 17 2008 11:00:00 GMT

Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing.

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on August 8, 2008, Fisher Clinical Services, Inc., 7554 Schantz Road, Allentown, Pennsylvania 18106, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Noroxymorphone (9668), a basic class of controlled substance listed in schedule II.

The company plans to import the listed substance for analytical research and clinical trials.

Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture s

Importer of Controlled Substances; Notice of Application

Fri, Oct 17 2008 11:00:00 GMT

Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing.

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on August 5, 2008, Noramco Inc., 500 Swedes Landing Road, Wilmington, Delaware 198014417, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Opium, Raw (9600) and Concentrate of Poppy Straw (9670), basic classes of controlled substances listed in schedule II.

The company plans to import the listed controlled substances to manufacture other controlled substances.

Any bulk manufacturer who is presently, or is applying to be,

Importer of Controlled Substances; Notice of Application

Fri, Oct 17 2008 11:00:00 GMT

Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a registration under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing.

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on September 4, 2008, Formulation Technologies LLC., 11400 Burnet Road, Suite 4010, Austin, Texas 78758, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Fentanyl (9801), a basic class of controlled substance listed in schedule II.

The company plans to import the listed controlled substance for analytical characterization, secondary packaging, and/or for distribution to clinical trial sites.

Any bulk manufacturer who is

Manufacturer of Controlled Substances; Notice of Application

Fri, Oct 17 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 5, 2008, Noramco Inc., Division of Ortho McNeil, Inc., 500 Swedes Landing Road, Wilmington, Delaware 198014417, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule CodeineNoxide (9053)..................... I
Dihydromorphine (9145)..................... I
MorphineNoxide (9307).................... I
Methylphenidate (1724)..................... II
Methylphenidate HCL (1726)................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Morphine (9300)............................ II
Thebaine (9333).................

Manufacturer of Controlled Substances; Notice of Application

Fri, Oct 17 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 10, 2008, Penick Corporation, 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by letter to the Drug Enforcement Administration (DEA) as a bulk manufacturer of Oripavine (9330), a basic class of controlled substance listed in schedule II.

The company will use the above listed controlled substance in the manufacture of other controlled substance intermediates for sale to its customers.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be fi

Manufacturer of Controlled Substances; Notice of Application

Fri, Oct 17 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 15, 2008, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 786652402, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of
[[Page 61910]]
controlled substances listed in schedules I and II:
Drug Schedule Cathinone (1235)............................ I
Methcathinone (1237)........................ I
NEthylamphetamine (1475)................... I
N,NDimethylamphetamine (1480).............. I
Aminorex (1585)............................. I
4Methylaminorex (cis isomer) (1590)........ I
GammaHydroxybutyric acid (2010)............ I
Methaqualone (2565)......................... I
Alphaethyltryptamine (7249)................ I
Lysergic acid diethylamide (7315)........... I
Marihuana (7360)............................ I
Tetrahydrocannabinols (7370)............

Manufacturer of Controlled Substances; Notice of Application

Fri, Oct 17 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 15, 2008, Noramco Inc., 1440 Olympic Dr., Athens, Georgia 30601, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule CodeineNOxide (9053)..................... I
MorphineNOxide (9307).................... I
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Morphine (9300)............................ II
Oripavine (9330)........................... II
Thebaine (9333)............................ II
Oxymorphone (9652)...............

Manufacturer of Controlled Substances; Notice of Application

Fri, Oct 17 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 5, 2008, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedule I:
Drug Schedule Marihuana (7360)........................... I

Tetrahydrocannabinols (7370)............... I

The company plans to manufacture small quantities of marihuana derivatives for research purposes. In reference to drug code 7360 (Marihuana), the company plans to bulk manufacture cannabidiol. In reference to drug code 7370 (Tetrahydrocannabinols), the company will manufacture a synthetic THC. No other activity for this drug code is authorized for registration.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may

Manufacturer of Controlled Substances; Notice of Registration

Fri, Oct 17 2008 11:00:00 GMT

By Notice dated June 20, 2008, and published in the Federal Register on June 27, 2008, (73 FR 36573), Archimica, Inc., 2460 W. Bennett Street, Springfield, Missouri 658071229, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Methylphenidate (1724)..................... II
Phenylacetone (8501)....................... II

Methadone Intermediate (9254).............. II

The company plans to manufacture the listed controlled substances in bulk for research purposes, and sale to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Archimica, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Archimica, Inc. to

Manufacturer of Controlled Substances; Notice of Registration

Fri, Oct 17 2008 11:00:00 GMT

By Notice dated April 28, 2008, and published in the Federal Register on May 2, 2008, (73 FR 24313), Abbott Laboratories, DBA Knoll Pharmaceutical Company, 30 North Jefferson Road, Whippany, New Jersey 07981, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule Dihydromorphine (9145).................... I

Hydromorphone (9150)...................... II

The company plans to manufacture bulk product and dosage units for distribution to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Abbott Laboratories to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Abbott Laboratories to ensure that the company'

Importer of Controlled Substances; Notice of Application

Tue, Oct 14 2008 11:00:00 GMT

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on August 26, 2008, Hospira Inc., 1776 North Centennial Drive, McPherson, Kansas 674601247, made application to the Drug Enforcement Administration (DEA) to be registered as an importer of Remifentanil (9739), a basic class of controlled substance listed in schedule II.

The company plans to import Remifentanil for use in dosage form manufacturing.

Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled subs

Manufacturer of Controlled Substances; Notice of Application

Tue, Oct 14 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 13, 2008, Halo Pharmaceutical Inc., 30 North Jefferson Road, Whippany, New Jersey 07981, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Dihydromorphine (9145)..................... I

Hydromorphone (9150)....................... II

Dihydromorphine is an intermediate in the manufacture of Hydromorphone and is not for commercial distribution. The company plans to manufacture Hydromorphone HCL for sale to other manufacturers and for the manufacture of other controlled substance dosage units for distribution to its customers.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the pro

Sunny Wholesale, Inc. Revocation of Registration and Denial of Application; Correction

Tue, Oct 14 2008 11:00:00 GMT

On October 3, 2008, the Drug Enforcement Administration (DEA) published an order in the Federal Register (73 FR 57655) that, among other things, revoked the registration of Sunny Wholesale, Inc. In the order taking this action, the DEA Certificate of Registration was incorrectly cited. The correct Certificate of Registration for Sunny Wholesale, Inc., 120 Forest Parkway, Forest Park, Georgia, is 004550SLY.

Therefore, the Certificate of Registration referenced at 73 FR 57668, first column, sixth line down, is corrected to read ``004550SLY.''

Dated: October 6, 2008.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E824305 Filed 101008; 8:45 am]
BILLING CODE 441009P

Importer of Controlled Substances; Notice of Application

Wed, Oct 8 2008 11:00:00 GMT

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on August 1, 2008, Clinical Supplies Management, Inc., 342 42nd Street, South Fargo, North Dakota 58103, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Sufentanil (9740), a basic class of controlled substance listed in schedule II.

The company plans to import the listed controlled substance for clinical trials, research, and analytical purposes.

Any bulk manufacturer who is presently, or is applying to be, registered wit

Manufacturer of Controlled Substances; Notice of Application

Wed, Oct 8 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 8, 2008, National Center for Natural Products ResearchNIDA MProject, University of Mississippi, 135 Coy Waller Complex, University, Mississippi 38677, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I:
Drug Schedule Marihuana (7360)........................... I

Tetrahydrocannabinols (7370)............... I

The company plans to cultivate marihuana for the National Institute on Drug Abuse for research approved by the Department of Health and Human Services.

Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comm

Sunny Wholesale, Inc.; Revocation of Registration and Denial of Application

Fri, Oct 3 2008 11:00:00 GMT

On August 24, 2005, I, the Deputy Administrator of the Drug Enforcement Administration, issued an Order to Show Cause and Immediate Suspension of Registration to Sunny Wholesale, Inc. (Respondent), of Forest Park, Georgia. ALJ Ex. 6. The Order immediately suspended Respondent's DEA Certificate of Registration, No. 004550SLY, which authorizes it to distribute the list I chemicals ephedrine and pseudoephedrine, on the ground that it was selling ``excessive amounts'' of these chemicals to convenience stores, id. at 6, which are the ``primary source'' for the diversion of these chemicals into the illicit manufacture of methamphetamine, a schedule II controlled substance.\1\ Id. at 4.
\1\ On October 20, 2004, the Deputy Assistant Administrator issued the initial Order to Show Cause to Respondent; the Order proposed the revocation of its registration at its Forest Park location and the denial of its pending application for a
registration at its Decatur, Georgia location. ALJ Ex. 1. Each of t

Importer of Controlled Substances; Notice of Registration

Mon, Sep 29 2008 11:00:00 GMT

By Notice dated March 11, 2008 and published in the Federal Register on March 19, 2008 (73 FR 14839), AllTech Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II: Drug Schedule Cocaine (9041)............................. II
Codeine (9050)............................. II
Hydrocodone (9193)......................... II
Meperidine (9230).......................... II
Methadone (9250)........................... II

Morphine (9300)............................ II

The company plans to import these controlled substances for the manufacture of reference standards.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of AllTech Associates Inc. to import the basic classes of controlled

Importer of Controlled Substances; Notice of Registration

Mon, Sep 29 2008 11:00:00 GMT

By Notice dated June 19, 2008 and published in the Federal Register on June 27, 2008 (73 FR 36572), Aptuit, 10245 Hickman Mills Drive, Kansas City, Missouri 64137, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Marihuana (7360), a basic class of controlled substance listed in schedule I.

The company plans to import a finished pharmaceutical product containing cannabis extracts in dosage form for packaging for a clinical trial study.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Aptuit to import the basic class of controlled substance is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Aptuit to ensure that the company's registration is consistent with the public interest. The investiga

Importer of Controlled Substances; Notice of Registration

Mon, Sep 29 2008 11:00:00 GMT

By Notice dated June 19, 2008 and published in the Federal Register on June 27, 2008 (73 FR 36571), Aptuit (Allendale) Inc., 75 Commerce Drive, Allendale, New Jersey 07401, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Noroxymorphone (9668), a basic class of controlled substance listed in schedule II.

The company plans to import the basic class of controlled substance for clinical trials and research.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Aptuit (Allendale) Inc. to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Aptuit (Allendale) Inc. to ensure that the company's registration is consistent with the public interest. The inve

Manufacturer of Controlled Substances; Notice of Registration

Mon, Sep 29 2008 11:00:00 GMT

By Notice dated March 19, 2008 and published in the Federal Register on March 28, 2008 (73 FR 16719), Alltech Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application to the Drug Enforcement Administration (DEA) to be registered as
[[Page 56614]]
a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Methcathinone (1237).............................. I
NEthylamphetamine (1475)......................... I
N,NDimethylamphetamine (1480).................... I
4Methylaminorex (cis isomer) (1590).............. I
Alphaethyltryptamine (7249)...................... I
Lysergic acid diethylamide (7315)................. I
2,5Dimethoxy4(n)propylthiophenethylamine I
(7348).
Tetrahydrocannabinols (7370)...................... I
Mescaline (7381).................................. I
4Bromo2,5dimethoxyamphetamine (7391)........... I
4Bromo2,5dimethoxyphenethylamine (7392)....

Manufacturer of Controlled Substances; Notice of Registration

Mon, Sep 29 2008 11:00:00 GMT

By Notice dated April 28, 2008 and published in the Federal Register on May 2, 2008 (73 FR 24313), Lin Zhi International Inc., 687 North Pastoria Avenue, Sunnyvale, California 94085, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule ........................... Tetrahydrocannabinols (7370)............... I
3,4Methylenedioxymethamphetamine (MDMA) I
(7405).
Cocaine (9041)............................. II
Oxycodone (9143)........................... II
Hydrocodone (9193)......................... II
Methadone (9250)........................... II
Dextropropoxyphene, bulk (nondosage forms) II
(9273).

Morphine (9300)............................ II

The company plans to manufacture the listed controlled substances as bulk reagents for use in drug abus

Manufacturer of Controlled Substances; Notice of Registration

Mon, Sep 29 2008 11:00:00 GMT

By Notice dated May 15, 2008 and published in the Federal Register on May 27, 2008 (73 FR 30418), Siegfried (USA), Inc., Industrial Park Road, Pennsville, New Jersey 08070, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Oripavine (9330), a basic class of controlled substance listed in schedule II.

The company will use the above listed controlled substance in the manufacture of other controlled substance intermediates for sale to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Siegfried (USA), Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Siegfried (USA), Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical se

Technical Amendment to Listing in Schedule III of Approved Drug Products Containing Tetrahydrocannabinols; Withdrawal

Mon, Sep 29 2008 11:00:00 GMT

DEA is withdrawing a proposed rule that was published in the Federal Register on September 24, 2007 (72 FR 54226) and is terminating the rulemaking. The proposed rule would have revised the DEA regulations with respect to the listing in schedule III of a synthetic isomer of tetrahydrocannabinols (THC) contained in a specific formulation of a drug product approved by the U.S. Food and Drug Administration (FDA). Specifically, the proposed rule would have revised the DEA regulation so that it would also include generic drug products approved by the FDA under section 505(j) of the Food, Drug, and Cosmetic Act (FDCA) (21 U.S.C. 355) that cite the drug product currently listed in schedule III as the reference listed drug. In view of the comments DEA received in response to the proposed rule, DEA has decidedin lieu of finalizing the proposed ruleto proceed with the process set out in 21 U.S.C. 811 for transferring each such generic drug individually to schedule III.

Importer of Controlled Substances; Notice of Application

Mon, Sep 29 2008 11:00:00 GMT

Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in schedule II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing.

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on August 18, 2008, GE Healthcare, 3350 North Ridge Avenue, Arlington Heights, Illinois 60004 1412, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as an importer of Cocaine (9041), a basic class of controlled substance listed in schedule II.

The company plans to import small quantities of ioflupane, in the form of three separate analogues of Cocaine, to validate production and QC systems; for a reference standard; and for producing material for fu

Manufacturer of Controlled Substances; Notice of Application

Mon, Sep 29 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 24, 2008, Johnson Matthey Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 080661742, made application by letter to the Drug Enforcement Administration (DEA) as a bulk manufacturer of Gamma Hydroxybutyric acid (2010), a basic class of controlled substance listed in schedule I.

The company plans on producing sodium oxybate for sale to its customers.

Manufacturer of Controlled Substances; Notice of Registration

Mon, Sep 29 2008 11:00:00 GMT

By Notice dated May 19, 2008 and published in the Federal Register on May 27, 2008 (73 FR 30418), AMRI Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:
Drug Schedule Marihuana (7360)............................ I
Tetrahydrocannabinols (7370)................ I
Amphetamine (1100).......................... II
Lisdexamfetamine (1205)..................... II
Methylphenidate (1724)...................... II
Pentobarbital (2270)........................ II
Hydrocodone (9193).......................... II
Meperidine (9230)........................... II
Dextropropoxyphene, bulk (nondosage form) II
(9273).
Oxymorphone (9652).......................... II

Fentanyl (9801)............................. II

The company plans to manufacture bulk contr

Importer of Controlled Substances; Notice of Registration

Mon, Sep 29 2008 11:00:00 GMT

By Notice dated June 3, 2008 and published in the Federal Register on June 10, 2008 (73 FR 32736), Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Phenylacetone (8501), a basic class of controlled substance listed in schedule II.

The company plans to import Phenylacetone for use as a precursor in the manufacture of amphetamine only.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Cambrex Charles City, Inc. to import the basic class of controlled substance is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Cambrex Charles City, Inc. to ensure that the company's registration is consistent with the public interest. The i

Manufacturer of Controlled Substances; Notice of Application

Fri, Sep 26 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 28, 2008, Mallinckrodt Inc., 3600 North Second Street, St. Louis, Missouri 63147, made application by letter to the Drug Enforcement Administration (DEA) as a bulk manufacturer of Oripavine (9330), a basic class of controlled substance listed in schedule II.

The company plans to use the above listed controlled substance as an intermediate in the manufacture of a noncontrolled product.

Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2009:

Fri, Sep 19 2008 11:00:00 GMT

This notice proposes the initial year 2009 assessment of annual needs for certain List I chemicals in accordance with the Combat Methamphetamine Epidemic Act of 2005 (CMEA), enacted on March 9, 2006. The Act required DEA to establish production quotas and import quotas for ephedrine, pseudoephedrine, and phenylpropanolamine. The enactment of the CMEA places additional regulatory controls upon the manufacture, distribution, importation, and exportation of the three List I chemicals.

Agency Information Collection Activities: Proposed Collection; Comments Requested: Application for Registration (DEA

Mon, Sep 15 2008 11:00:00 GMT

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted until November 14, 2008. This process is conducted in accordance with 5 CFR 1320.10.

If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information,
[[Page 53279]]
please contact Mark W. Caverly, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152, Telephone (202) 3077297.

Written comments and suggestions from the public and affected agenci

Agency Information Collection Activities: Proposed Collection; Comments Requested: Application for Registration (DEA

Mon, Sep 15 2008 11:00:00 GMT

If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Mark W. Caverly, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152, Telephone (202) 307 7297.

Written comments and suggestions from the public and affected agencies concerning

Agency Information Collection Activities: Proposed Collection; Comments Requested: Application for Registration (DEA

Mon, Sep 15 2008 11:00:00 GMT

If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Mark W. Caverly, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152, Telephone (202) 307 7297.

Written comments and suggestions from the public and affected agencies concerning

Manufacturer of Controlled Substances; Notice of Application; Correction

Mon, Sep 15 2008 11:00:00 GMT

On August 6, 2008, the Drug Enforcement Administration (DEA) published a Notice of Application for Registration for Chattem Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409 in the Federal Register pursuant to 21 CFR 1301.33(a) (73 FR 45784). On May 28,
[[Page 53281]]
2008, Chattem Chemicals Inc., had made application by renewal to DEA as a bulk manufacturer of the certain basic classes of controlled substances listed in schedules I and II. The Notice of Application published August 6, 2008, listed the following basic classes of controlled substances for which Chattem Chemicals Inc. sought registration as a bulk manufacturer:
Drug Schedule 4Methoxyamphetamine (7411)............... I
Difenoxin (9168).......................... I
Amphetamine (1100)........................ II
Methamphetamine (1105).................... II
Methylphenidate (1724).................... II
Pentobarbital (2270)...................

Novelty Distributors, Inc.; Revocation of Registration

Wed, Sep 10 2008 11:00:00 GMT

On January 17, 2008, I, the Deputy Administrator of the Drug Enforcement Administration, issued an Order to Show Cause and Immediate Suspension of Registration to Novelty Distributors, Inc. (Respondent), of Greenfield, Indiana. The Order immediately suspended and proposed the revocation of Respondent's DEA Certificate of Registration, 003563NSY, as a distributor of the list I chemicals ephedrine and pseudoephedrine, on the grounds that its ``continued registration is inconsistent with the public interest,'' and ``constitute[d] an imminent danger to public health and safety.'' Show Cause Order at 1 (ALJ EX. 1) (citing 21 U.S.C. 823(h), 824(a)(4), and 824(d)).

More specifically, the Show Cause Order alleged that Respondent was storing listed chemical products at, and distributing them from, over 100 unregistered locations throughout the United States, in violation of Federal law and regulations. Id. (citing 21 U.S.C. 822(e), 21 CFR 1309.21 and 1309.23(a)).

Next, the Show Cause Order al

Elmer P. Manalo, M.D.; Dismissal of Proceeding

Tue, Aug 26 2008 11:00:00 GMT

On August 30, 2007, I, the Deputy Administrator of the Drug Enforcement Administration, issued an Order to Show Cause and Immediate Suspension of Registration to Elmer P. Manalo, M.D. (Respondent), of Greensburg, Indiana. The immediate suspension of Respondent's registration was based on my preliminary finding that Respondent posed an ``imminent danger to public health or safety'' because he prescribed schedule II and IV controlled substances to undercover law enforcement personnel on numerous occasions without a legitimate medical purpose and outside the scope of his professional practice. Show Cause Order at 1. The Show Cause Order further alleged that Respondent continued to prescribe controlled substances to certain persons notwithstanding that he had been specifically informed that these persons ``were illegitimate drug seekers and addicts,'' and that several of his patients had ``died due to mixed drug intoxication or accidental drug overdose.'' Id. at 2.

Following service of the

Janet L. Thornton, D.O.; Dismissal of Proceeding

Tue, Aug 26 2008 11:00:00 GMT

On December 17, 2007, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, issued an Order to Show Cause to Janet L. Thornton, D.O. (Respondent), of Monument, Colorado. The Show Cause Order sought the revocation of Respondent's DEA Certificate of Registration, AT2730984, as a practitioner, and the denial of any pending applications to renew or modify her registration, on two separate grounds.

First, it alleged that Respondent had entered into a series of stipulations with the Colorado Board of Medical Examiners under which she agreed that she ``will not practice medicine in the State of Colorado.'' Show Cause Order at 2. Relatedly, the Show Cause Order alleged that Respondent's ``Colorado medical license expired on May 31, 2007, and has not been renewed,'' and that therefore Respondent lacks state authority to handle controlled substances, which is a prerequisite for holding a DEA registration. Id.

Second, the Show Cause Order alleged that

Agency Information Collection Activities: Proposed Collection; Comments Requested

Mon, Aug 25 2008 11:00:00 GMT

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will
[[Page 50056]]
be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted until October 24, 2008. This process is conducted in accordance with 5 CFR 1320.10.

If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Mark W. Caverly, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152, Telephone (202) 307 7297.

Written comments and suggestions from the public and affected agenci

Manufacturer of Controlled Substances; Notice of Registration

Wed, Aug 6 2008 11:00:00 GMT

By Notice dated March 28, 2008, and published in the Federal Register on April 4, 2008 (73 FR 18570), Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Tetrahydrocannabinols (7370)................ I
Methylphenidate (1724)...................... II
Codeine (9050).............................. II
Dihydrocodeine (9120)....................... II
Oxycodone (9143)............................ II
Hydromorphone (9150)........................ II
Hydrocodone (9193).......................... II
Oripavine (9330)............................ II
Thebaine (9333)............................. II
Oxymorphone (9652).......................... II
Noroxymorphone (9668)....................... II
Fentanyl (9801)............................. I

Manufacturer of Controlled Substances; Notice of Registration

Wed, Aug 6 2008 11:00:00 GMT

By Notice dated March 27, 2008, and published in the Federal Register on April 2, 2008 (73 FR 18001), Lonza Riverside, 900 River Road, Conshohocken, Pennsylvania 19428, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Gamma hydroxybutyric acid (2010)............ I
Amphetamine (1100).......................... II

Methylphenidate (1724)...................... II

The company plans to manufacture bulk products for finished dosage units and distribution to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Lonza Riverside to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Lonza Riverside to ensure that th

Manufacturer of Controlled Substances; Notice of Registration

Wed, Aug 6 2008 11:00:00 GMT

By Notice dated March 28, 2008, and published in the Federal Register on April 4, 2008 (73 FR 18570), Siegfried (USA), Inc., Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Dihydromorphine (9145)...................... I
Amphetamine (1100).......................... II
Methamphetamine (1105)...................... II
Methylphenidate (1724)...................... II
Amobarbital (2125).......................... II
Pentobarbital (2270)........................ II
Secobarbital (2315)......................... II
Glutethimide (2550)......................... II
Codeine (9050).............................. II
Oxycodone (9143)............................ II
Hydromorphone (9150)........................ II
Hydrocodone (9193)..........................

Importer of Controlled Substances; Notice of Application

Wed, Aug 6 2008 11:00:00 GMT

Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this is notice that on May 27, 2008, Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Methamphetamine (1105)...................... II
Phenylacetone (8501)........................ II
Raw Opium (9600)............................ II

Concentrate of Poppy Straw (9670)........... II

The company plans to import the listed controlled substances to manufacture bulk controlled substances for sale to its customers.

No comments, objections, or requests for any hearings will be accepted on any application for registration or reregistration to import crude opium, poppy straw, concentrate of poppy straw, and coca leaves. As explained in the Correction to Notice of

Manufacturer of Controlled Substances; Notice of Registration

Wed, Aug 6 2008 11:00:00 GMT

By Notice dated March 10, 2008 and published in the Federal Register on March 19, 2008 (73 FR 14840), Mallinckrodt, Inc., 3600 North Second Street, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Tetrahydrocannabinols (7370)............... I
CodeineNoxide (9053)..................... I
Dihydromorphine (9145)..................... I
Difenoxin (9168)........................... I
MorphineNoxide (9307).................... I
Normorphine (9313)......................... I
Norlevorphanol (9634)...................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Nabilone (7379)............................ II
Codeine (9050)............................. II
Diprenorphine (9058).

Importer of Controlled Substances; Notice of Application

Wed, Aug 6 2008 11:00:00 GMT

Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on June 11, 2008, Almac Clinical Services Inc. (ACSI), 2661 Audubon Road, Audubon, Pennsylvania 19403, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Oxycodone (9143)............................ II

Fentanyl (9801)............................. II

The company plans to import small quantities of the listed controlled substances in dos

Manufacturer of Controlled Substances; Notice of Registration

Wed, Aug 6 2008 11:00:00 GMT

By Notice dated March 11, 2008 and published in the Federal Register on March 19, 2008 (73 FR 14841), Varian, Inc., Lake Forest, 25200 Commercentre Drive, Lake Forest, California 926308810, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Phencyclidine (7471)....................... II
1Piperidinocyclohexanecarbonitrile (8603) II

Benzoylecgonine (9180)..................... II

The company plans to manufacture small quantities of the listed controlled substances for use in diagnostic products.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Varian, Inc. to manufacture the listed
[[Page 45789]]
basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Va

Importer of Controlled Substances; Notice of Application

Wed, Aug 6 2008 11:00:00 GMT

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on June 2, 2008, Wildlife Laboratories, 1401 Duff Drive, Suite 400, Fort Collins, Colorado 80524, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Etorphine Hydrochloride (9059), a basic class of controlled substance listed in schedule II.

The company plans to import the listed controlled substance for sale to its customers.

Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture su

Manufacturer of Controlled Substances; Notice of Registration

Wed, Aug 6 2008 11:00:00 GMT

By Notice dated April 9, 2008, and published in the Federal Register on April 16, 2008, (73 FR 20718), Research Triangle Institute, Kenneth H. Davis Jr., Hermann Building, East Institute Drive, P.O. Box 12194, Research Triangle, North Carolina 27709, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I

Cocaine (9041)............................. II

The Institute will manufacture small quantities of cocaine and marihuana derivatives for use by their customers in analytical kits, reagents, and reference standards as directed by the National Institute on Drug Abuse.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of

Importer of Controlled Substances; Notice of Application

Wed, Aug 6 2008 11:00:00 GMT

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on March 26, 2008, BA Research International LLC, 10550 Rockley Road, Suite 150, Houston, Texas 77099 0000, made application to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule 4Methylaminorex (cis isomer) (1590)........ I
Gamma Hydroxybutyric Acid (2010)............ I
Methaqualone (2565)......................... I
Ibogaine (7

Importer of Controlled Substances; Notice of Application

Wed, Aug 6 2008 11:00:00 GMT

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on June 5, 2008, Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Phenylacetone (8501), a basic class of controlled substance listed in schedule II.

The company plans to import the listed controlled substance to bulk manufacture amphetamine.

Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufactu

Importer of Controlled Substances; Notice of Registration

Wed, Aug 6 2008 11:00:00 GMT

By Notice dated March 10, 2008 and published in the Federal Register on March 19, 2008, (73 FR 14839), Roche Diagnostics Operations, Inc., Attn: Regulatory Compliance, 9115 Hague Road, Indianapolis, Indiana 46250, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule Lysergic acid diethylamide (7315).......... I
Alphamethadol (9605)....................... I
Tetrahydrocannabinols (7370)............... I
Cocaine (9041)............................. II
Ecgonine (9180)............................ II
Methadone (9250)........................... II

Morphine (9300)............................ II

The company plans to import the listed controlled substances for the manufacture of diagnostic products for distribution to its customers.

No comments or objections have been received. DEA has considered the fac

Importer of Controlled Substances; Notice of Registration

Wed, Aug 6 2008 11:00:00 GMT

By Notice dated February 12, 2008 and published in the Federal Register on February 21, 2008, (73 FR 9591), United States Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852, made application to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Cathinone (1235)............................ I
Methaqualone (2565)......................... I
Lysergic acid diethylamide (7315)........... I
Marihuana (7360)............................ I
Tetrahydrocannabinols (7370)................ I
4Methyl2,5dimethoxyamphetamine (7395).... I
3,4Methylenedioxyamphetamine (7400)........ I
Codeinenoxide (9053)...................... I
Heroin (9200)............................... I
Amphetamine (1100).......................... II
[[Page 45782]]
Methamphetamine (1105)...................... II
Phenmetrazine (1631).....................

Importer of Controlled Substances; Notice of Registration

Wed, Aug 6 2008 11:00:00 GMT

By Notice dated April 9, 2008 and published in the Federal Register on April 16, 2008, (73 FR 20715), Research Triangle Institute, Kenneth H. Davis, Jr., Hermann Building, East Institute Drive, P.O. Box 12194, Research Triangle, North Carolina 27709, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule 1(1Phenylcyclohexyl)pyrrolidine (7458).... I
1[1(2Thienyl)cyclohexy]piperidine (7470). I
1[1(2Thienyl)cyclohexyl]pyrrolidine I
(7473).
1Methyl4phenyl4propionoxypiperidine I
(9661).
1(2Phenylethyl)4phenyl4 I
acetoxypiperidine (9663).
2,5Dimethoxy4(n)propylthiophenethylamine I
(7348).
2,5Dimethoxy4ethylamphetamine (7399)..... I
2,5Dimethoxyamphetamine (7396)............. I
3,4,5Trimethoxyamphetamine (7390).......... I
3,4Methylenedioxyamphetamine (7400)........ I
3,4Methylene

Manufacturer of Controlled Substances; Notice of Registration

Wed, Aug 6 2008 11:00:00 GMT

By Notice dated March 19, 2008 and published in the Federal Register on March 28, 2008, (73 FR 16719), Sigma Aldrich Research Biochemicals, Inc., 43 Strathmore Road, Natick, Massachusetts 01760 2447, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule Cathinone (1235)........................... I
Methcathinone (1237)....................... I
Aminorex (1585)............................ I
Alphaethyltryptamine (7249)............... I
Lysergic acid diethylamide (7315).......... I
Tetrahydrocannabinols (7370)............... I
4Bromo2,5dimethoxyamphetamine (7391).... I
4Bromo2,5dimethoxyphenethylamine (7392). I
2,5Dimethoxyamphetamine (7396)............ I
3,4Methylenedioxyamphetamine (7400)....... I
NHydroxy3,4methylenedioxy amphetamine I
(7402).
3,4MethylenedioxyNethylamphetamine I
(740

Manufacturer of Controlled Substances; Notice of Application

Wed, Aug 6 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 3, 2008, Chemic Laboratories, Inc., 480 Neponset Street, Building 7, Canton, Massachusetts 02021, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of Cocaine (9041), a basic class of controlled substance listed in schedule II.

The company plans to manufacture small quantities of the above listed controlled substance for distribution to its customers for the purpose of research.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substance, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Manufacturer of Controlled Substances; Notice of Application

Wed, Aug 6 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 28, 2008, Chattem Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule 4Methoxyamphetamine (7411)................. I
Difenoxin (9168)............................ I
Amphetamine (1100).......................... II
Methamphetamine (1105)...................... II
Methylphenidate (1724)...................... II
Pentobarbital (2270)........................ II
Codeine (9050).............................. II
Oxycodone (9143)............................ II
Hydrocodone (9193).......................... II
Meperidine (9230)........................... II
Dextropropoxyphene, bulk (nondosage forms) II
(9273).
Morphine (9300)..........

Manufacturer of Controlled Substances; Notice of Application

Wed, Aug 6 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 3, 2008, Cambridge Isotope Lab, 50 Frontage Road, Andover, Massachusetts 01810, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of Morphine (9300), a basic class of controlled substance listed in schedule II.

The company plans to utilize small quantities of the listed controlled substance in the preparation of analytical standards.

Manufacturer of Controlled Substances; Notice of Application

Wed, Aug 6 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 28, 2008, Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Amphetamine (1100).......................... II
Lisdexamfetamine (1205)..................... II
Methylphenidate (1724)...................... II
Methadone (9250)............................ II
[[Page 45785]]

Methadone intermediate (9254)............... II

The company plans to manufacture the listed controlled substances in bulk for sale to its customers for formulation into finished pharmaceuticals.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuanc

Manufacturer of Controlled Substances; Notice of Application

Wed, Aug 6 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 11, 2008, American Radiolabeled Chemical, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Gamma hydroxybutyric acid (2010)............ I
Ibogaine (7260)............................. I
Lysergic acid diethylamide (7315)........... I
Tetrahydrocannabinols (7370)................ I
Dimethyltryptamine (7435)................... I
1[1(2Thienyl)cyclohexyl]piper idine I
(7470).
Dihydromorphine (9145)...................... I
Normorphine (9313).......................... I
Amphetamine (1100).......................... II
Methamphetamine (1105)...................... II
Amobarbital (2125).......................... II
Phencyclidine (7471).....................

Manufacturer of Controlled Substances; Notice of Application

Wed, Aug 6 2008 11:00:00 GMT

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 23, 2008, Austin Pharma, LLC., 811 Paloma Drive, Suite A, Round Rock, Texas 786652402, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Alphamethadol (9605)....................... I
Nabilone (7379)............................ II
Methadone (9250)........................... II
Methadone Intermediate (9254).............. II
Levoalphacetylmethadol (9648)............. II
Alfentanil (9737).......................... II
Remifentanil (9739)........................ II
Sufentanil (9740).......................... II

Fentanyl (9801)............................ II

The company plans to manufacture the